Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
作者信息
Chataway Jeremy
机构信息
Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, London, UK.
出版信息
Mult Scler. 2017 Apr;23(4):505-506. doi: 10.1177/1352458516671821. Epub 2016 Oct 11.
PMID:27729554
Abstract
摘要
Zotero 插件